Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Mar;23(6):1910-21.
doi: 10.1128/MCB.23.6.1910-1921.2003.

Regulation of TATA-binding protein binding by the SAGA complex and the Nhp6 high-mobility group protein

Affiliations

Regulation of TATA-binding protein binding by the SAGA complex and the Nhp6 high-mobility group protein

Yaxin Yu et al. Mol Cell Biol. 2003 Mar.

Abstract

Transcriptional activation of the yeast HO gene involves the sequential action of DNA-binding and chromatin-modifying factors. Here we examine the role of the SAGA complex and the Nhp6 architectural transcription factor in HO regulation. Our data suggest that these factors regulate binding of the TATA-binding protein (TBP) to the promoter. A gcn5 mutation, eliminating the histone acetyltransferase present in SAGA, reduces the transcription of HO, but expression is restored in a gcn5 spt3 double mutant. We conclude that the major role of Gcn5 in HO activation is to overcome repression by Spt3. Spt3 is also part of SAGA, and thus two proteins in the same regulatory complex can have opposing roles in transcriptional regulation. Chromatin immunoprecipitation experiments show that TBP binding to HO is very weak in wild-type cells but markedly increased in an spt3 mutant, indicating that Spt3 reduces HO expression by inhibiting TBP binding. In contrast, it has been shown previously that Spt3 stimulates TBP binding to the GAL1 promoter as well as GAL1 expression, and thus, Spt3 regulates these promoters differently. We also find genetic interactions between TBP and either Gcn5 or the high-mobility-group protein Nhp6, including multicopy suppression and synthetic lethality. These results suggest that, while Spt3 acts to inhibit TBP interaction with the HO promoter, Gcn5 and Nhp6 act to promote TBP binding. The result of these interactions is to limit TBP binding and HO expression to a short period within the cell cycle. Furthermore, the synthetic lethality resulting from combining a gcn5 mutation with specific TBP point mutations can be suppressed by the overexpression of transcription factor IIA (TFIIA), suggesting that histone acetylation by Gcn5 can stimulate transcription by promoting the formation of a TBP/TFIIA complex.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
spt mutations allow HO expression in the absence of Gcn5. S1 nuclease protection assays were performed with probes specific for HO and CMD1 (internal control). RNAs were prepared from the following strains: (A) DY150, DY5925, DY1696, and DY5929; (B) DY150, DY5925, DY6219, and DY6277; (C) DY150, DY5925, DY6178, and DY6422; (D) DY151, DY5926, and DY6603; (E) FY61 and FY1006; (F) DY150 and DY6707; (G) DY150 and DY6404.
FIG. 2.
FIG. 2.
spt3 effect is independent of SBF. S1 nuclease protection assays were performed with probes specific for HO and CMD1 (internal control). RNAs were prepared from the following strains: (A) DY150, DY6758, and DY6760; (B) DY5454, DY5457, DY7206, and DY7202; (C) DY150, DY2382, and DY6778. (D) The upper map shows the positions of the Swi5-binding sites in URS1, the SBF binding sites in URS2, and the TATA element of the HO promoter, as well as the region that is subject to GCN5-dependent histone acetylation (26). The lower map shows the ΔURS2 version of the HO promoter.
FIG. 3.
FIG. 3.
Suppression of growth phenotypes by spt3. (A) The following strains were plated on YEPD medium and grown for 5 days at 37°C: DY2381, DY6778, and DY6728. (B) The following strains were plated on YEPD medium and grown for 4 days at 30°C: DY6857, DY6776, and DY6771.
FIG. 4.
FIG. 4.
Suppression by overexpression of TBP. (A) Strain DY6155 (nhp6a nhp6b) was transformed with plasmids YEp351 (YEp-LEU2 vector) or pSH223 (YEp-LEU2 with TBP), and dilutions were plated on YEPD and grown for 2 days at 38°C. (B) RNA was prepared from cells grown without uracil to select for plasmids and used for S1 nuclease protection assays. RNAs were prepared from the following strains: DY3398 (wild type) with YEplac195 vector, DY5199 (gcn5) with YEplac195 vector, DY5199 (gcn5) with pJG18-2 (YEp-URA3 with TBP), DY3398 (wild type) with YEplac195 vector, DY6441 (nhp6a nhp6b) with YEplac195 vector, and DY6441 (nhp6a nhp6b) with pJG18-2 (YEp-URA3 with TBP).
FIG. 5.
FIG. 5.
Genetic interactions with TBP. (A) Strain DY7244 (nhp6a nhp6b spt15 with wild-type TBP on a YCp-URA3 plasmid) was transformed with the indicated YCp-TRP1 plasmid, and dilutions were plated on either synthetic complete or 5-FOA plates and grown for 3 days at 30°C. (B) Strain DY7242 (spt15 with wild-type TBP on a YCp-URA3 plasmid) was transformed with the indicated YCp-TRP1 plasmid, and dilutions were plated on either synthetic complete or 5-FOA plates and grown for 3 days at 30°C. (C) Strain DY7723 (nhp6a nhp6b spt15 spt3 with wild-type TBP on a YCp-URA3 plasmid) was transformed with the indicated YCp-TRP1 plasmid, and dilutions were grown at 30°C on either YEPD plates for 3 days or 5-FOA plates for 4 days. (D) Strain DY7515 (gcn5 spt15 with wild-type TBP on a YCp-URA3 plasmid) was transformed with the indicated YCp-TRP1 plasmid, and dilutions were grown at 30°C on either YEPD plates for 3 days or 5-FOA plates for 4 days.
FIG. 6.
FIG. 6.
TFIIA overexpression suppresses the gcn5 TBP(K138T, Y139A) synthetic lethality. Strain DY8158 (gcn5 spt15 with wild-type TBP on a YCp-URA3 plasmid) was transformed with either M4493 [TBP(K138T, Y139A) in YCp-TRP1] or pDE58-1 [TBP(G174E) in YCp-TRP1] and either YEp351 or pSH346 (LEU2), selecting for the TRP1 and LEU2 plasmids. Transformants were grown on 5-FOA plates for either 7 days at 25°C (left half) or 3 days at 30°C (right half).
FIG. 7.
FIG. 7.
spt3-401 suppresses spt15-21 for growth and HO expression. (A) Isogenic strains were constructed, differing at the GCN5, SPT15 and SPT3 loci. The gcn5 spt15-21 double mutant had a severe growth defect, but this was suppressed specifically by the spt3-401 allele. The following strains were grown on YEPD medium for 2 days at 30°C: DY151, DY7593, DY5926, DY7597, DY7598, and DY7604. (B) RNA was prepared from the following strains and used for S1 nuclease protection assays: DY151, DY7593, DY7592, DY7594, DY5926, DY7597, DY7596, and DY7598.
FIG. 8.
FIG. 8.
Spt3 inhibits TBP binding to HO. SPT3 (DY7247) and spt3 (DY7250) strains with a TBP-HA tag were synchronized, and at timed intervals, samples were taken for RNA analysis and chromatin immunoprecipitation. (A) S1 nuclease protection assays showed that HO RNA levels were higher in the spt3 mutant. (B) Chromatin immunoprecipitation (ChIP) analysis showed increased TBP-HA binding to the HO TATA in spt3 mutants. PGK1 TATA and the TRA1 open reading frame served as positive and negative controls for the chromatin immunoprecipitation.
FIG. 9.
FIG. 9.
Model for the differential regulation of TBP binding by Spt3. The Gcn5 module also contained Ada2 and Ada3. In addition to Spt7 and Spt20, the SAGA core also contained Ada1, TAF90, TAF61, TAF60, TAF25, TAF17, and Tra1. The Spt3 module also contained Spt8. At GAL1 and other promoters, Spt3 promoted TBP binding and Gcn5 was not required (4, 17). At HO, Gcn5 and Nhp6 stimulated TBP binding while Spt3 inhibited binding.

Similar articles

Cited by

References

    1. Agalioti, T., S. Lomvardas, B. Parekh, J. Yie, T. Maniatis, and D. Thanos. 2000. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell 103:667-678. - PubMed
    1. Arndt, K. M., S. L. Ricupero, D. M. Eisenmann, and F. Winston. 1992. Biochemical and genetic characterization of a yeast TFIID mutant that alters transcription in vivo and DNA binding in vitro. Mol. Cell. Biol. 12:2372-2382. - PMC - PubMed
    1. Belotserkovskaya, R., D. E. Sterner, M. Deng, M. H. Sayre, P. M. Lieberman, and S. L. Berger. 2000. Inhibition of TATA-binding protein function by SAGA subunits Spt3 and Spt8 at Gcn4-activated promoters. Mol. Cell. Biol. 20:634-647. - PMC - PubMed
    1. Bhaumik, S. R., and M. R. Green. 2002. Differential requirement of SAGA components for recruitment of TATA-box-binding protein to promoters in vivo. Mol. Cell. Biol. 22:7365-7371. - PMC - PubMed
    1. Bhoite, L. T., and D. J. Stillman. 1998. Residues in the Swi5 zinc finger protein that mediate cooperative DNA-binding with the Pho2 homeodomain protein. Mol. Cell. Biol. 18:6436-6446. - PMC - PubMed

Publication types

MeSH terms

Substances